Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Immunol., 15 December 2025

Sec. Autoimmune and Autoinflammatory Disorders: Autoinflammatory Disorders

Volume 16 - 2025 | https://doi.org/10.3389/fimmu.2025.1743471

Correction: Association of clinical features and myositis-specific antibodies in idiopathic inflammatory myopathy: a retrospective study from southern China

This article is a correction to:

  1. Association of clinical features and myositis-specific antibodies in idiopathic inflammatory myopathy: a retrospective study from southern China

    1. Read original article
Can Li&#x;Can Li1†Yushi Zheng&#x;Yushi Zheng1†Yu Zhang,Yu Zhang1,2Yujin YeYujin Ye1Hui ZhangHui Zhang1Niansheng YangNiansheng Yang1Shuang Wang*Shuang Wang1*
  • 1Department of Rheumatology, First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
  • 2Department of Medicine, Traditional Chinese Medicine Hospital of Laifeng County, Enshi, Hubei, China

A Correction on
Association of clinical features and myositis-specific antibodies in idiopathic inflammatory myopathy: a retrospective study from southern China

By Li C, Zheng Y, Zhang Y, Ye Y, Zhang H, Yang N and Wang S (2025) Front. Immunol. 16:1674437. doi: 10.3389/fimmu.2025.1674437

There was a mistake in Figure 1C as published. The original, incorrect text was “MSA(+)&MAA(-)”. The correct text should be “MSA(+)&MAA(±)”. The corrected Figure 1 appears below.

Figure 1
Distribution of myositis-related antibodies is shown in two bar graphs and a flowchart. Graph A depicts the positive and negative citation counts of various antibodies, with Anti-MDA5 having the highest positive count at 69. Graph B shows Anti-ARS antibody types, with Anti-Jo-1 having a positive count of 30. The flowchart in section C, regarding IIM patients, illustrates distribution based on MSA and MAA positivity, leading to subcategories including single-positive, double-positive, and triple-positive MSAs.

Figure 1. The distribution of myositis-related antibodies in IIM patients. (A) The distribution of MSAs in 208 IIM patients. (B) Distribution of various anti-ARS antibodies in anti-ARS positive patients. (C) Profiles of MSA and MAA positivity in IIM patients.

The original version of this article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: idiopathic inflammatory myopathy, myositis-associated autoantibody, myositis-specific autoantibody, interstitial lung disease, malignancy, cardiac involvement, hyperlipidemia

Citation: Li C, Zheng Y, Zhang Y, Ye Y, Zhang H, Yang N and Wang S (2025) Correction: Association of clinical features and myositis-specific antibodies in idiopathic inflammatory myopathy: a retrospective study from southern China. Front. Immunol. 16:1743471. doi: 10.3389/fimmu.2025.1743471

Received: 10 November 2025; Accepted: 08 December 2025; Revised: 17 November 2025;
Published: 15 December 2025.

Edited and reviewed by:

Alexandre Wagner Silva De Souza, Federal University of São Paulo, Brazil

Copyright © 2025 Li, Zheng, Zhang, Ye, Zhang, Yang and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Shuang Wang, d2FuZ3NoOEBtYWlsLnN5c3UuZWR1LmNu

†These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.